calcium channel blockersbeta-blockersMigraine headachesmigraine
…t common limitation (110 trials, 55.3%). Compared with placebo, calcium channel blockers (mean difference (MD) −1.78 (95% CI −2.96 to −0.60), moderate c…
27articles mentioning drugs
38drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Beta-blockers ×
Beta-blockers
This drug is selected. Its supporting articles are shown below.
Articles mentioning Beta-blockers
27 articles · page 1 of 3Aspirinbeta-blockersstatinsStatinACEiproton pump inhibitorsACE inhibitorsPPIsBeta-blockerAcute Coronary Syndrome+1 more
…cribed (%) N = 76 Improvement (%) p-value Significant? (p<0.05) Aspirin 221 (100) 76 (100) 0 - - Beta-blocker 156 (70.6) 69 (90.8) +20.…
digoxinamiodaroneflecainidebeta-blockersamiodarone-associated
…blockers, amiodarone, flecainide, calcium channel blockers, and digoxin, which are commonly prescribed for rhythm management in these p…
beta-blockersLipid-lowering medication905Type 2 diabetes746type 2 diabetesdiabetes
…en HRV frequency-domain z-score and PWV. Excluding people using beta-blockers raised the estimates for the type 2 diabetes group in the analy…
metoprololBBbeta-blockersbeta-blockerHHFT
… at higher rates compared to older generation machines. Reduced metoprolol requirements materially improves workflow, removing time spent …
rifaximinbeta-blockersdiureticscirrhosistertiary hepatology centre
…s) and liver-related pharmacotherapy (beta-blockers, diuretics, rifaximin) were collected. Models using baseline variables to predict 6-m…
propranololrivaroxabanatenololVKAsbeta-blockersceliac diseaseportal cavernoma cholangiopathy (PCC)diabetesanticoagulationtuberculosis+3 more
… (64.5%; rivaroxaban: 80%, VKAs: 20%) and beta-blockers (61.3%; propranolol: 52.6%, atenolol: 47.4%). Diuretics were added in 26.3% for asc…
beta-blockersstatinscyclo-oxygenase-2 inhibitorsUniversity College LondonDoctor Peset University Hospitaladult-onset cancerGeneral University Hospital of Valencia
…with routine medications—statins, cyclo-oxygenase-2 inhibitors, beta-blockers—remain poorly understood. Whether overnight in-bedroom PM2.5 ai…
beta-blockersacute myocardial infarctionPubMedrecurrent myocardial infarctionCochrane LibraryGoogle Scholarstrokebeta-blocker therapy
… with acute myocardial infarction and preserved LVEF, long-term beta-blockers showed no reduction in mortality, recurrent MI, stroke, MACE, o…
Beta-blockersmyocardial infarctionPubMedMIEmbaseBeta-blocker therapyScopus
…Introduction Beta-blockers are routinely prescribed following myocardial infarction (MI) d…
ACE inhibitorsARNisangiotensin receptor blockersbeta-blockersmineralocorticoid receptor antagonistsangiotensin receptor-neprilysin inhibitorsacute heart failure
… (40%). In patients with reduced LVEF, the prescription rate of ACE inhibitors, angiotensin receptor blockers or angiotensin receptor-neprilys…
beta-blockersSGLT2imineralocorticoid receptor antagonistssodium-glucose cotransporter-2 inhibitorsARNIrenin-angiotensin system inhibitorsangiotensin receptor-neprilysin inhibitorsHeart failure (HF)quadruple therapy
…the consolidation of four foundational pharmacological pillars: beta-blockers, renin-angiotensin system inhibitors or angiotensin receptor-ne…